Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Jared Weiss, MD, of UNC Lineberger, Chapel Hill, NC, explores the impact of antibiotic use on the efficacy of checkpoint inhibitor therapies based on changes in the gut microbiome. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).